$ATAO
ALTAIR INTERNATIONAL CORP.

2024 Q3 Form 10-Q Financial Statement

#000155479524000215 Filed on August 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $36.15K $34.79K
YoY Change -27.7% -14.96%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $36.15K $34.79K
YoY Change -31.09% -14.97%
Operating Profit -$36.15K -$34.79K
YoY Change -31.09% -14.97%
Interest Expense $2.998K $8.558K
YoY Change -92.34% -75.11%
% of Operating Profit
Other Income/Expense, Net -$2.998K -$8.558K
YoY Change -124.21% -93.42%
Pretax Income -$39.15K -$43.34K
YoY Change -2.31% -74.65%
Income Tax
% Of Pretax Income
Net Earnings -$39.15K -$43.34K
YoY Change -2.31% -74.65%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 32.80M shares 31.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $460.00 $7.210K
YoY Change -95.4% -74.91%
Cash & Equivalents $461.00 $7.211K
Short-Term Investments
Other Short-Term Assets $4.200K
YoY Change 5.26%
Inventory
Prepaid Expenses $4.200K
Receivables
Other Receivables
Total Short-Term Assets $461.00 $11.41K
YoY Change -97.12% -65.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $461.00 $11.41K
Total Long-Term Assets $0.00 $0.00
Total Assets $461.00 $11.41K
YoY Change -97.12% -65.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.000K $5.000K
YoY Change -13.21%
Accrued Expenses $17.88K $15.55K
YoY Change -70.2% -62.95%
Deferred Revenue
YoY Change
Short-Term Debt $155.6K $170.6K
YoY Change -2.74% 82.82%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $230.1K $217.6K
YoY Change -38.35% -37.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $230.1K $217.6K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $230.1K $217.6K
YoY Change -38.35% -37.82%
SHAREHOLDERS EQUITY
Retained Earnings -$17.60M -$17.56M
YoY Change 1.56% 1.57%
Common Stock $32.80K $31.98K
YoY Change 32.85% 29.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$229.6K -$206.1K
YoY Change
Total Liabilities & Shareholders Equity $461.00 $11.41K
YoY Change -97.12% -65.13%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$39.15K -$43.34K
YoY Change -2.31% -74.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$32.95K -$23.49K
YoY Change -34.1% -6.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.20K $26.40K
YoY Change -12.67% 5.6%
NET CHANGE
Cash From Operating Activities -32.95K -$23.49K
Cash From Investing Activities
Cash From Financing Activities 26.20K $26.40K
Net Change In Cash -6.750K $2.913K
YoY Change -66.25% -1943.67%
FREE CASH FLOW
Cash From Operating Activities -$32.95K -$23.49K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001570937
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
shares
CY2024Q2 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
usd
CY2024Q2 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
usd
CY2024Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2024Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
usd
CY2024Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17558753 usd
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
ALTAIR INTERNATIONAL CORP.
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q2 dei Entity File Number
EntityFileNumber
333-190235
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385465
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
322 North Shore Drive
CY2024Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1B, Suite 200
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15212
CY2024Q2 dei City Area Code
CityAreaCode
412
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
770-3140
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32803527 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7211 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4298 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4200 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6500 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
11411 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
10798 usd
CY2024Q2 us-gaap Assets
Assets
11411 usd
CY2024Q1 us-gaap Assets
Assets
10798 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
15549 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
13029 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
5210 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
156444 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
166234 usd
CY2024Q2 ATAO Current Liabilities Due To Related Party
CurrentLiabilitiesDueToRelatedParty
26400 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
217558 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
193428 usd
CY2024Q2 us-gaap Liabilities
Liabilities
217558 usd
CY2024Q1 us-gaap Liabilities
Liabilities
193428 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31975852 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31975852 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30238686 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30238686 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
31976 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
30239 usd
CY2024Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
58938 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17320630 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17243603 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17558753 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17515410 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-206147 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-182630 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11411 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10798 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12000 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12000 usd
CY2024Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
2500 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7500 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20285 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21409 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
34785 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
40909 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34785 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-40909 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
8558 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
34384 usd
CY2023Q2 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-84795 usd
CY2023Q2 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
10872 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8558 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130051 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-43343 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-170960 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-43343 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2024Q2 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.00
CY2023Q2 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.01
CY2024Q2 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
31378033 shares
CY2023Q2 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24692449 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-182630 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
15826 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-43343 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-206147 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-317150 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-43343 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2024Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5210 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
31306 usd
CY2023Q2 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
10872 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-84795 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2300 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3990 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2261 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9500 usd
CY2024Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3346 usd
CY2023Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3078 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23487 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25158 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000 usd
CY2024Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26400 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26400 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2913 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-158 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4298 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7211 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28739 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
15826 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zCVwb44egU9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_zHYtnRPi2HA2">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zSR41q2O3qwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_862_zYJL8wz04rHf">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2024Q2 ATAO Note Holder
NoteHolder
EROP Enterprises (2)
CY2024Q2 ATAO Stock Issued During Period Shares Transfer Agent Issuance For Debt Conversion
StockIssuedDuringPeriodSharesTransferAgentIssuanceForDebtConversion
785833 shares
CY2024Q2 ATAO Conversion Of Common Stock Principal Amount
ConversionOfCommonStockPrincipalAmount
15000 usd
CY2024Q2 ATAO Conversion Of Common Stock Interest Amount
ConversionOfCommonStockInterestAmount
827 usd
CY2024Q2 ATAO Conversion Of Common Stock Shares
ConversionOfCommonStockShares
791333 shares
us-gaap Officers Compensation
OfficersCompensation
12000 usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
12000 usd
CY2024Q2 ATAO Common Stock Issued For Compensation Expense Shares
CommonStockIssuedForCompensationExpenseShares
160000 shares
CY2024Q2 ATAO Common Stock Issued For Compensation Expense Amount
CommonStockIssuedForCompensationExpenseAmount
4000 usd
CY2024Q2 ATAO Advances From Related Party For Operating Expenses
AdvancesFromRelatedPartyForOperatingExpenses
26400 usd
CY2024Q3 ATAO Conversion Of Common Stock Shares1
ConversionOfCommonStockShares1
130194 shares
CY2024Q3 ATAO Conversion Of Common Stock Shares2
ConversionOfCommonStockShares2
697481 shares

Files In Submission

Name View Source Status
0001554795-24-000215-index-headers.html Edgar Link pending
0001554795-24-000215-index.html Edgar Link pending
0001554795-24-000215.txt Edgar Link pending
0001554795-24-000215-xbrl.zip Edgar Link pending
atao-20240630.xsd Edgar Link pending
atao0814form10q.htm Edgar Link pending
atao0814form10qexh31_1.htm Edgar Link pending
atao0814form10qexh32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
atao-20240630_def.xml Edgar Link unprocessable
atao-20240630_cal.xml Edgar Link unprocessable
atao-20240630_lab.xml Edgar Link unprocessable
atao-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atao0814form10q_htm.xml Edgar Link completed